Arkolith/Insider Trading/NUTX/Form 4

Vo Thomas T.

Chief Executive Officer, DirectorNutex Health, Inc. (NUTX) · full profile →Form 4 · filed Nov 21, 2023
Net Buying
Open-Market Buys
$115K
Open-Market Sells
$0
Net Open-Market Flow
$115K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2023Buy(P)275K$0.23$63K269.8M
Nov 17, 2023Buy(P)225K$0.23$52K269.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001486189-23-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML